Skip to content
  • Team
  • Portfolio
  • Our Approach
  • Community
  • Investor Portal

NuScriptRX names new CEO

NuScriptRX names new CEO

3810 Bedford Avenue
Suite 110
Nashville, TN 37215
(615) 454-3950(615) 454-3950
2022 ANNUAL REPORT
  • Twitter
  • Linked
© 2023 Nashville Capital Network. Finely Crafted by Proof Branding